Champions Oncology, Inc.

NasdaqCM:CSBR 주식 보고서

시가총액: US$64.2m

이 페이지의 번역은 실험적이며 개발 중입니다. 여러분의 환영합니다!

Champions Oncology 관리

관리 기준 확인 4/4

Champions Oncology's CEO는 Ronnie Morris, Jan2017 에 임명되었습니다 의 임기는 7.58 년입니다. 총 연간 보상은 $ 600.00K, 66.7% 로 구성됩니다. 66.7% 급여 및 33.3% 보너스(회사 주식 및 옵션 포함). 는 $ 3.87M 가치에 해당하는 회사 주식의 6.32% 직접 소유합니다. 3.87M. 경영진과 이사회의 평균 재임 기간은 각각 2.9 년과 13.2 년입니다.

주요 정보

Ronnie Morris

최고 경영자

US$400.0k

총 보상

CEO 급여 비율100.0%
CEO 임기7.7yrs
CEO 소유권6.3%
경영진 평균 재임 기간3yrs
이사회 평균 재임 기간13.3yrs

최근 관리 업데이트

Recent updates

It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Jun 14
It's A Story Of Risk Vs Reward With Champions Oncology, Inc. (NASDAQ:CSBR)

Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Sep 28
Is Now The Time To Put Champions Oncology (NASDAQ:CSBR) On Your Watchlist?

Champions Oncology Non-GAAP EPS of -$0.02, revenue of $12.9M

Jul 21

We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

Oct 14
We Think Some Shareholders May Hesitate To Increase Champions Oncology, Inc.'s (NASDAQ:CSBR) CEO Compensation

We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Jun 21
We Think Champions Oncology (NASDAQ:CSBR) Can Afford To Drive Business Growth

Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Apr 09
Are Investors Undervaluing Champions Oncology, Inc. (NASDAQ:CSBR) By 44%?

Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

Mar 19
Here's Why We're Not At All Concerned With Champions Oncology's (NASDAQ:CSBR) Cash Burn Situation

The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Mar 02
The Champions Oncology (NASDAQ:CSBR) Share Price Has Gained 243%, So Why Not Pay It Some Attention?

Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Feb 04
Is There Now An Opportunity In Champions Oncology, Inc. (NASDAQ:CSBR)?

Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Jan 14
Do Insiders Own Lots Of Shares In Champions Oncology, Inc. (NASDAQ:CSBR)?

Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Dec 19
Philip Breitfeld Is The Chief Strategy & Innovation Officer and Director of Champions Oncology, Inc. (NASDAQ:CSBR) And They Just Sold 100% Of Their Shares

Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Dec 16
Champions Oncology, Inc. (NASDAQ:CSBR) Analysts Are Pretty Bullish On The Stock After Recent Results

Champions Oncology beats on revenue

Dec 14

Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

Dec 04
Estimating The Fair Value Of Champions Oncology, Inc. (NASDAQ:CSBR)

CEO 보상 분석

Ronnie Morris 의 보수는 Champions Oncology 의 수익과 비교하여 어떻게 변경되었나요?
날짜총 보상급여회사 수익
Jul 31 2024n/an/a

-US$3m

Apr 30 2024US$400kUS$400k

-US$7m

Jan 31 2024n/an/a

-US$10m

Oct 31 2023n/an/a

-US$10m

Jul 31 2023n/an/a

-US$8m

Apr 30 2023US$600kUS$400k

-US$5m

Jan 31 2023n/an/a

-US$3m

Oct 31 2022n/an/a

US$108k

Jul 31 2022n/an/a

US$401k

Apr 30 2022US$800kUS$400k

US$548k

Jan 31 2022n/an/a

US$219k

Oct 31 2021n/an/a

US$391k

Jul 31 2021n/an/a

US$115k

Apr 30 2021US$775kUS$375k

US$362k

Jan 31 2021n/an/a

-US$1m

Oct 31 2020n/an/a

-US$2m

Jul 31 2020n/an/a

-US$1m

Apr 30 2020US$1mUS$394k

-US$2m

Jan 31 2020n/an/a

-US$181k

Oct 31 2019n/an/a

-US$956k

Jul 31 2019n/an/a

-US$995k

Apr 30 2019US$146kUS$146k

US$128k

Jan 31 2019n/an/a

-US$251k

Oct 31 2018n/an/a

US$42k

Jul 31 2018n/an/a

-US$320k

Apr 30 2018US$244kn/a

-US$1m

보상 대 시장: Ronnie 의 총 보상 ($USD 400.00K ) US 시장에서 비슷한 규모의 회사에 대한 평균보다 낮습니다( $USD 683.22K ).

보상과 수익: Ronnie 의 보상은 지난 한 해 동안 회사 성과와 일치했습니다.

CEO

Ronnie Morris (58 yo)

7.7yrs

테뉴어

US$400,000

보상

Dr. Ronnie Morris, M.D. has been Chief Executive Officer at Champions Oncology, Inc. since January 31, 2017. Dr. Morris previously served as the President and a Director of Champions Oncology, Inc. from Oc...

리더십 팀

이름위치테뉴어보상소유권
Ronnie Morris
CEO & Director7.7yrsUS$400.00k6.32%
$ 4.1m
Brady Davis
Presidentless than a yearUS$1.35m0%
$ 0
David Miller
Chief Financial Officer7.3yrsUS$260.00k0.041%
$ 26.0k
Maria Mancini
Chief Operating Officer1.2yrs데이터 없음데이터 없음
Arthur Hanson
Vice President of Technology4.3yrs데이터 없음데이터 없음
Rachel Bunting
Vice President of Global Marketingno data데이터 없음데이터 없음
David DeOrnellis
Executive Vice President of Global Laboratory Operations3yrs데이터 없음데이터 없음
Michael Ritchie
Chief Commercial Officerno data데이터 없음데이터 없음
Karin Heidemann
Executive Vice President of Global Scientific Operations3yrs데이터 없음데이터 없음
Marianna Zipeto
Executive Vice President of Commercial1.2yrs데이터 없음데이터 없음

3.0yrs

평균 재임 기간

55yo

평균 연령

경험이 풍부한 관리: CSBR 의 관리팀은 경험 ( 2.9 년 평균 재직 기간)으로 간주됩니다.

이사회 구성원

이름위치테뉴어보상소유권
Ronnie Morris
CEO & Director13.9yrsUS$400.00k6.32%
$ 4.1m
Scott Tobin
Independent Director13.3yrsUS$93.30k0.22%
$ 141.6k
Joel Ackerman
Independent Chairman of the Board13.9yrsUS$116.62k6.3%
$ 4.0m
David Sidransky
Independent Lead Director17.1yrsUS$85.54k5.64%
$ 3.6m
René Bernards
Scientific Advisorno data데이터 없음데이터 없음
Manuel Hidalgo
Scientific Advisorno data데이터 없음데이터 없음
Daniel Mendelson
Independent Director11.5yrsUS$85.52k1.46%
$ 937.5k
Harvey Pass
Scientific Advisorno data데이터 없음데이터 없음
Philip Breitfeld
Independent Director8.4yrsUS$85.54k0.11%
$ 69.1k
Misti Ushio
Board Observerno data데이터 없음데이터 없음
Justin Stebbing
Scientific Advisorno data데이터 없음데이터 없음
Robert Brainin
Independent Director3.6yrsUS$82.20k0%
$ 0

13.3yrs

평균 재임 기간

58.5yo

평균 연령

경험이 풍부한 이사회: CSBR 의 이사회는 노련하고 경험이 있습니다(평균 재직 기간 13.2 년).